Literature DB >> 2693968

Bronchoalveolar lavage in an immunosuppressed rabbit model of invasive pulmonary aspergillosis.

E R Chilvers1, C L Spreadbury, J Cohen.   

Abstract

A rabbit model of invasive aspergillosis has been used to investigate the pathogenesis of Aspergillus infection in the immunosuppressed host. The animals received hydrocortisone daily and a single dose of cyclophosphamide 2 days prior to intratracheal instillation of conidia from Aspergillus fumigatus. Bronchoalveolar lavage (BAL) was performed in 3 infected and 2 control saline treated animals sacrificed on days 1, 2, 4, 7 and 10 following inoculation. Infective load within the lung was quantified using an assay for chitin which is an important component of fungal cell walls (in particular the hyphal cell wall) and is not present in vertebrate tissue. The total BAL white cell count did not discriminate between infected and saline treated animals and Aspergillus was cultured from one lavage specimen only. Infected animals developed a marked neutrophil alveolitis by day 2 in contrast to a near total absence of neutrophils in the lavages of the control animals. Phagocytosis of conidia by alveolar macrophages was prominent but did not prevent progressive infection as confirmed by measurement of lung chitin. This pattern of cellular response within the alveolar airspace reflects the complex nature of the response to Aspergillus infection in the immunosuppressed host.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693968     DOI: 10.1007/bf00436221

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  18 in total

1.  Effect of cortisone on bronchopulmonary aspergillosis in mice exposed to spores of various Aspergillus species.

Authors:  D K Sandhu; R S Sandhu; V N Damodaran; H S Randhawa
Journal:  Sabouraudia       Date:  1970-05

2.  The pathogenesis of experimental pulmonary aspergillosis. An ultrastructural study of alveolar macrophages after phagocytosis of a flavus spores in vivo.

Authors:  L P Merkow; S M Epstein; H Sidransky; E Verney; M Pardo
Journal:  Am J Pathol       Date:  1971-01       Impact factor: 4.307

Review 3.  Clinical applications of bronchoalveolar lavage: an interim view.

Authors:  M E Turner-Warwick; P L Haslam
Journal:  Br J Dis Chest       Date:  1986-04

4.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S L Gerson; G H Talbot; S Hurwitz; B L Strom; E J Lusk; P A Cassileth
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

5.  In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus.

Authors:  A R Waldorf; S M Levitz; R D Diamond
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

6.  Invasive aspergillosis: clinical and pathological features of a new animal model.

Authors:  C L Spreadbury; T Krausz; S Pervez; J Cohen
Journal:  J Med Vet Mycol       Date:  1989

7.  Growth of Cryptococcus neoformans within human macrophages in vitro.

Authors:  R D Diamond; J E Bennett
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

8.  Detection of galactomannan antigenemia by enzyme immunoassay in experimental invasive aspergillosis.

Authors:  L de Repentigny; M Boushira; L Ste-Marie; G Bosisio
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

9.  Immunodiagnosis of invasive pulmonary aspergillosis in rabbits. Fungal antigen detected by radioimmunoassay in bronchoalveolar lavage fluid.

Authors:  C P Andrews; M H Weiner
Journal:  Am Rev Respir Dis       Date:  1981-07

10.  The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes.

Authors:  J Thompson; R van Furth
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

View more
  8 in total

1.  Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.

Authors:  Thomas J Walsh; Sylvain Goutelle; Roger W Jelliffe; Jeffrey A Golden; Emily A Little; Catherine DeVoe; Diana Mickiene; Maggie Hayes; John E Conte
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

Review 2.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

3.  Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis.

Authors:  T Madan; U Kishore; M Singh; P Strong; E M Hussain; K B Reid; P U Sarma
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 4.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 5.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

6.  Intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole at steady state in healthy subjects.

Authors:  John E Conte; Jeffrey A Golden; Gopal Krishna; Marina McIver; Emily Little; Elisabeth Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

Review 7.  Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Front Microbiol       Date:  2017-05-16       Impact factor: 5.640

Review 8.  Animal models: an important tool in mycology.

Authors:  Javier Capilla; Karl V Clemons; David A Stevens
Journal:  Med Mycol       Date:  2007-12       Impact factor: 4.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.